We're an early-stage company developing Floura, a non-invasive approach to at-home preeclampsia screening, with the aim of exploring what screening could look like between prenatal visits.
Pregnancy care is built around appointments, but health-related changes don't always follow a schedule. Our mission is to explore approaches that could help address the gap between prenatal visits, starting with preeclampsia, a serious complication of pregnancy.
Preeclampsia assessment can involve blood pressure measurements, clinical evaluation, and laboratory testing during prenatal care. The timing and type of assessment depend on individual circumstances and clinical guidance.
Milnura is exploring the opportunity to complement appointment-based care by investigating approaches designed for use between visits. This work remains in development and is not intended to replace prenatal appointments, clinical assessment, or advice from healthcare professionals.
Floura is being developed around the exploration of breath and urine biomarkers together. The concept is to investigate whether combining multiple types of biomarker information could inform an approach designed for use at home.
The technology, intended use, and potential role in prenatal care remain under development and evaluation. Floura is not currently available for clinical use.
Responsible, grounded development shaped by transparency and clinical perspective.
We value perspectives from clinicians, researchers, nurses, midwives, doulas, and mothers. These conversations help us understand the needs, questions, and practical considerations that should inform our development process.
We're an early-stage company. We communicate openly about what we're exploring, what remains uncertain, and what still needs to be developed and evaluated.
We're exploring a non-invasive, at-home approach with everyday usability in mind, while recognising the importance of appropriate clinical oversight.
Floura is in early development. Right now we're focused on research and development, building our first proof of concept, and growing a network of clinical and scientific advisors.
Our name blends milagro, Spanish for miracle, and nourrir, French for to nourish. Nourishing miracles is what we want to protect.
We're building relationships with people who care about the future of maternal health. If you're a clinician, researcher, advisor, or funder, we'd like to hear from you.